建業地產(00832.HK):贖回2021年到期3.63億美元優先票據
格隆匯11月8日丨建業地產(00832.HK)公佈,有關2021年11月到期票息6.75%優先票據("2021年11月票據")。2021年11月票據為於新加坡證券交易所有限公司上市,並於2021年11月8日到期。
公司已以贖回價按全部未償還的2021年11月票據本金金額(即3.63億美元),連同截至到期日(但不包括該日)止累計應付利息1225.87萬美元全部贖回未償還的2021年11月票據。公司已於到期日支付贖回價3.75億美元。
公司認為,票據贖回不會對其財務狀況構成重大影響。票據贖回完成後,全部2021年11月票據將予以註銷並從新加坡證券交易所有限公司正式名單中除牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.